skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: THE EFFECT OF LANTHANIDES AND ACTINIDES ON BLOOD COAGULATION. I. EVIDENCE FOR AND PROPERTIES OF A NEW SERUM THROMBOPLASTIC FACTOR

Journal Article · · Journal of Clinical Investigation (U.S.)
DOI:https://doi.org/10.1172/JCI104955· OSTI ID:4025772

Thorotrast in vivo promptly induces retarded coagulation and in vitro a profound inability of both plasma and serum to support thromboplastin generation. The same abnormality is induced in seram by thorium chloride and the related elements, Nd, La, Ce, and U. The plasma defect consists of progressive inactivation of accelerator globulin (Factor V). The serum defect involves an entity distinct from any hithento known clotting factor or intermediate. It is adsorbable by BaSO/sub 4/, elutable by citrate, and it is demonstrable in the protein fraction precipitated at 50 to 60% (NH/sub 4/)/sub 2/SO/sub 4/. The vulnerable factor in serum (TVF) is relatively labi1e, was separated from the other coagulation factors by physicochemical means, and can be markedly activated by trypsin. Replacing Inosithin by normal platelets in the thromboplastin generation mixture corrects the Th-induced defect. In contrast, Th-treated platelets are inert. Citrate and oxalate completely reverse the Th-induced defect, but EDTA is ineffective. It is suggested that the lanthanldes and actinldes produce a defect in serum by forming a reversible complex with a serum protein, which is a hitherto unrecognized clotting factor necessary for thromboplastin generation. The mechanism by which the biologic function of this protein is comprised by this group of elements, structurally similar atomically, appears to be reversible chelation at specific sites on the protein essential for its clotting activity. (auth)

Research Organization:
Beth Israel Hospital, Boston and Harvard Univ., Boston
Sponsoring Organization:
USDOE
NSA Number:
NSA-18-019535
OSTI ID:
4025772
Journal Information:
Journal of Clinical Investigation (U.S.), Vol. Vol: 43; Other Information: Orig. Receipt Date: 31-DEC-64
Country of Publication:
Country unknown/Code not available
Language:
English